Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Plos One|November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survivalMichelle Afkhami, Daniel Schmolze, Susan E Yost, et al.
Cell Reports|January 2, 2026
Spatially distinct cellular and molecular landscapes define prognosis in triple-negative breast cancerKavitha Mukund, Darya Veraksa, David Frankhouser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2017
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or FulvestrantPei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya, et al.
The Journal of Investigative Dermatology|November 14, 2021
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell LymphomaZhen Han, Renee J Estephan, Xiwei Wu, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|November 24, 2020
Physics approaches to the spatial distribution of immune cells in tumorsClare C Yu, Juliana C Wortman, Ting-Fang He, et al.
NPJ Breast Cancer|July 2, 2021
Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcomeJuliana C Wortman, Ting-Fang He, Shawn Solomon, et al.
Cancer Immunology Research|July 25, 2024
Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast CancerColt A Egelston, Weihua Guo, Diana L Simons, et al.
Breast Cancer Research : BCR|November 10, 2019
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancerJin Sun Lee, Susan E Yost, Suzette Blanchard, et al.
Pageof 6